iTeos Therapeutics, Inc. (ITOS) - Quarterly Income Statement

Home
ITOS
Financials

11.59 (USD) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	35	0	-11.303	0	0	12.595	53.905	19.487	41.716	152.522	240.504	104.271	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0.309	0.303	0.233	0.224	0.198	0.224	0.226	0.203	0.202	0.18	0.163	0	0.2	0.126	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	34.691	-0.303	-11.536	-0.224	-0.198	12.371	53.679	19.284	41.514	152.342	240.341	104.271	-0.2	-0.126	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0.991	0	1.021	0	0	0.982	0.996	0.99	0.995	0.999	0.999	1	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	36.4	34.225	27.777	30.638	29.186	25.598	25.421	23.932	26.91	21.096	17.386	16.102	14.238	11.643	9.212	8.726	6.137	5.825	5.96	4.998	3.902	4.351
General & Administrative Expenses Numbers are in millions	12.457	12.703	12.369	12.642	13.435	11.927	11.101	10.76	11.471	10.615	9.598	8.761	15.101	7.046	5.729	4.799	2.394	2.418	2.276	2.699	2.093	1.769
Selling & Marketing Expenses Numbers are in millions	0	0.001	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	12.457	12.704	12.369	12.642	13.435	11.927	11.101	10.76	11.471	10.615	9.598	8.761	15.101	7.046	5.729	4.799	2.394	2.418	2.276	2.699	2.093	1.769
Other Expenses Numbers are in millions	0.067	2.093	1.213	0.771	0.326	-1.078	-1.381	-0.698	-0.439	-0.745	9.567	-8.484	0.06	0.24	-0.283	0.265	0.012	1.223	0.945	-0.232	-0.535	0.756
Operating Expenses Numbers are in millions	48.857	46.929	37.243	42.232	41.436	36.447	35.141	33.994	37.942	30.966	26.027	23.374	26.519	13.774	14.62	10.953	7.264	6.47	6.289	6.66	5.162	5.158
Operating Income Numbers are in millions	-14.166	-47.232	-40.146	-43.28	-42.621	-24.93	17.383	-15.205	3.335	120.811	213.52	79.408	-29.339	-18.689	-14.941	-13.525	-8.531	-8.243	-8.236	-7.697	-5.995	-6.12
Operating Income Ratio Numbers are in millions	-0.405	0	3.552	0	0	-1.979	0.322	-0.78	0.08	0.792	0.888	0.762	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	8.406	10.428	1.213	0.771	0.326	10.578	5.363	13.219	5.108	-1.278	9.567	-8.484	0.06	0.24	-0.283	0.265	0.012	1.223	0.945	-0.232	-0.535	0.756
Income Before Tax Numbers are in millions	-5.76	-36.804	-28.188	-33.422	-33.068	-14.352	22.746	-1.986	8.443	119.533	224.044	72.413	-26.459	-13.534	-14.903	-10.688	-7.252	-5.247	-5.344	-6.892	-5.697	-4.402
Income Before Tax Ratio Numbers are in millions	-0.165	0	2.494	0	0	-1.139	0.422	-0.102	0.202	0.784	0.932	0.694	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	1.368	1.412	2.363	-1.181	1.232	1.199	2.293	-2.977	2.817	49.951	39.172	2.771	-0.119	0	0.001	-0.008	-0.05	0	0.032	0.029	0.058	0
Net Income Numbers are in millions	-7.128	-38.216	-30.551	-32.241	-34.3	-15.551	20.453	0.991	5.626	69.582	184.872	69.642	-26.459	-13.534	-14.904	-10.68	-7.202	-5.247	-5.376	-6.921	-5.755	-4.402
Net Income Ratio Numbers are in millions	-0.204	0	2.703	0	0	-1.235	0.379	0.051	0.135	0.456	0.769	0.668	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.18	-1.07	-0.85	-0.9	-0.96	-0.44	0.57	0.026	0.15	1.82	5.26	1.98	-0.75	-0.39	-0.61	-0.44	-0.23	-0.17	-0.54	-0.7	-0.58	-0.44
EPS Diluted Numbers are in millions	-0.18	-1.07	-0.85	-0.9	-0.96	-0.44	0.54	0.026	0.15	1.82	4.89	1.86	-0.75	-0.39	-0.61	-0.44	-0.23	-0.17	-0.54	-0.7	-0.58	-0.44
EBITDA Numbers are in millions	-13.857	-46.929	-37.016	-42.008	-41.211	-23.63	18.987	-14.302	3.969	121.736	214.628	81.073	-26.369	-13.648	-14.477	-10.811	-7.135	-6.349	-5.209	-6.502	-5.004	-5.009
EBITDA Ratio Numbers are in millions	-0.396	0	3.275	0	0	-1.876	0.352	-0.734	0.095	0.798	0.892	0.778	0	0	0	0	0	0	0	0	0	0

iTeos Therapeutics, Inc.

NASDAQ:ITOS Add to watchlist

NASDAQ:ITOS